CDKN2A and neoplasm: Elevated expression of CDKN2A (also known as tumour suppressor INK4A or p16) is often used as a surrogate marker for HPV infection.50 Not surprisingly, expression of CDKN2A was 114 times higher in HPV16+ HNSC tumours compared with the controls and 34 times higher compared with HPV− tumours.